You are here

LONGEVICA PHARMACEUTICALS, INC.

Company Information
Address
7 Deer Park Drive
Monmouth Junction, NJ 08852-1921
United States



Information

DUNS: 830042557

# of Employees: 5


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Use of EF2K inhibitors to inhibit tumor growth and sensitize cancer cells to existing chemotherapy treatment

    Amount: $221,987.00

    DESCRIPTION provided by applicant Eukaryotic elongation factor protein kinase eEF K is a ubiquitously expressed protein that belongs to a family of alpha kinases characterized by an andquot aty ...

    STTRPhase I2015Department of Health and Human Services National Institutes of Health
  2. Use of EF2K Inhibitors to Reduce Toxicity to Normal Tissues in Chemotherapy

    Amount: $222,039.00

    DESCRIPTION (provided by applicant): Eukaryotic elongation factor 2 protein kinase (eEF2K) is a ubiquitously expressed protein that belongs to a family of alpha kinases characterized by an atypical ...

    STTRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government